Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2020-01-31 2020-01-31
Drug Identification Number 02415542 02415542
Brand name APO-AZITHROMYCIN Z APO-AZITHROMYCIN Z
Common or Proper name AZITHROMYCIN AZITHROMYCIN
Company Name APOTEX INC APOTEX INC
Ingredients AZITHROMYCIN AZITHROMYCIN
Strength(s) 250MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 6 BLS 6 BLS
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-13 2020-01-13
Estimated end date 2020-01-31 2020-01-31
Actual end date 2020-01-30 2020-01-30
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments